Physician profile
Yi Qin
NPI 1104168368
$1,193.34
in general payments reported to CMS, 2019-2025
10 companies · $291 in 2025
The $291 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $45.44 · 2023: $241 · 2024: $617 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,147.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $380.09 | 2022-2025 | |
| Steris Corporation | $180.49 | 2024 | |
| Phathom Pharmaceuticals, INC. | $133.87 | 2024-2025 | Voquezna |
| Regeneron Healthcare Solutions, INC. | $116.83 | 2023-2024 | Dupixent |
| Medtronic, INC. | $109.75 | 2024 | Gi Genius |
| Novo Nordisk INC | $100.34 | 2024 | Wegovy |
| Takeda Pharmaceuticals U.S.A., INC. | $80.35 | 2025 | Eohilia |
| Ardelyx, INC. | $39.22 | 2023 | Ibsrela |
| Abiomed | $28.08 | 2025 | |
| Ironwood Pharmaceuticals, INC | $24.32 | 2023 | Linzess |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yi Qin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.